Sihuan Pharmaceutical Holdings Group Ltd. engages in the research and development, manufacture, and sale of pharmaceutical products. The company is headquartered in Beijing, Beijing. The company went IPO on 2010-10-28. The firm operates its business through three segments. The Medical Aesthetic Products segment includes the filling, shaping, supporting, supplementing, optoelectronic device, body sculpturing, skin care and others to provide non- or minimally invasive medical aesthetic comprehensive solutions. The Innovative Medicine and Other Medicine segment is engaged in the research and development and commercialization of innovative medicine in the disease fields of diabetes, breast cancer, digestion disorders, oncology and non-alcoholic steatohepatitis and others. The Generic Medicine segment is engaged in the production and sale of generic medicine including Kelin’ao and other products. The firm conducts its business in the domestic and overseas markets.
Follow-Up Questions
Sihuan Pharmaceutical Holdings Group Ltd 的 CEO 是谁？
Dr. Weicheng Guo 是 Sihuan Pharmaceutical Holdings Group Ltd 的 Executive Deputy Chairman of the Board，自 2006 加入公司。
SHPHY 股票的价格表现如何？
SHPHY 的当前价格为 $0，在上个交易日 decreased 了 0%。
Sihuan Pharmaceutical Holdings Group Ltd 的主要业务主题或行业是什么？
Sihuan Pharmaceutical Holdings Group Ltd 属于 Pharmaceuticals 行业，该板块是 Health Care
Sihuan Pharmaceutical Holdings Group Ltd 的市值是多少？
Sihuan Pharmaceutical Holdings Group Ltd 的当前市值是 $0
Sihuan Pharmaceutical Holdings Group Ltd 是买入、卖出还是持有？
